| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |